{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:55:09Z","timestamp":1791262509043,"version":"4.1.0"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110547","type":"journal-article","created":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:24:03Z","timestamp":1789914243000},"page":"110547","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis, structure\u2013activity relationship and in-silico studies of novel pyrazolo[1,5-a]pyrimidine derivatives as selective COX-2 inhibitors with promising anti-inflammatory activity and safety profile"],"prefix":"10.1016","volume":"182","author":[{"given":"Alaa Omar Mohamed","family":"Helmy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azza T.","family":"Taher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman Z.","family":"El Razaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem A.","family":"Abdel-Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed E.","family":"Abo-El Fetoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba","family":"M.Hesham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalal A.","family":"Abou El Ella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110547_bb0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cca.2019.06.019","article-title":"Metabolic syndrome is an inflammatory disorder: a conspiracy between adipose tissue and phagocytes","volume":"496","author":"Reddy","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bioorg.2026.110547_bb0010","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.18632\/oncotarget.23208","article-title":"Inflammatory responses and inflammation-associated diseases in organs","volume":"9","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2026.110547_bb0015","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-024-01528-7","article-title":"Targeting inflammation as cancer therapy","volume":"17","author":"Wang","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bioorg.2026.110547_bb0020","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41573-020-0082-8","article-title":"Kinase inhibition in autoimmunity and inflammation","volume":"20","author":"Zarrin","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.110547_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/cells13221899","article-title":"Resolution of chronic inflammation, restoration of epigenetic disturbances and correction of Dysbiosis as an adjunctive approach to the treatment of atopic dermatitis","volume":"13","author":"Livshits","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.bioorg.2026.110547_bb0030","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1096\/fj.201601222R","article-title":"Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms","volume":"31","author":"Serhan","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.bioorg.2026.110547_bb0035","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1021\/jm0613166","article-title":"Structural and functional basis of cyclooxygenase inhibition","volume":"50","author":"Blobaum","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110547_bb0040","first-page":"1396.2","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs)","volume":"346","author":"RO","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.bioorg.2026.110547_bb0045","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.biochi.2010.09.009","article-title":"Targeting cyclooxygenases-1 and -2 in neuroinflammation: therapeutic implications","volume":"93","author":"A\u00efd","year":"2011","journal-title":"Biochimie"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110547_bb0050","first-page":"655","article-title":"Selective COX-2 inhibitors: a review of their structure-activity relationships","volume":"10","author":"Zarghi","year":"2011","journal-title":"Iran. J. Pharm. Res."},{"issue":"14","key":"10.1016\/j.bioorg.2026.110547_bb0055","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.2174\/1381612053764896","article-title":"The role of COX-2 in acute pain and the use of selective COX-2 inhibitors for acute pain relief","volume":"11","author":"Lee","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bioorg.2026.110547_bb0060","article-title":"Effects of non-steroidal anti-inflammatory drugs (NSAIDs) and gastroprotective NSAIDs on the gastrointestinal tract: a narrative review","volume":"15","author":"Sohail","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.bioorg.2026.110547_bb0065","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.3390\/ph15101165","article-title":"Rational design and synthesis of new selective COX-2 inhibitors with in vivo PGE2-lowering activity by tethering benzenesulfonamide and 1,2,3-triazole pharmacophores to some NSAIDs","volume":"15","author":"El-Dershaby","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2026.110547_bb0070","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1021\/acsmedchemlett.5b00485","article-title":"Discovery of pyrazolo[1,5-a]pyrimidine TTK inhibitors: CFI-402257 is a potent, selective, bioavailable anticancer agent","volume":"7","author":"Liu","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110547_bb0075","author":"Harmal"},{"key":"10.1016\/j.bioorg.2026.110547_bb0080","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/10426500902922933","article-title":"Synthesis and antimicrobial activity of some new 5-Arylazothiazole, pyrazolo[1,5-a] pyrimidine, [1,2,4]triazolo[4,3-a]pyrimidine, and pyrimido[1,2-a]benzimidazole derivatives containing the thiazole moiety","volume":"185","author":"Abdelhamid","year":"2010","journal-title":"Phosphorus Sulfur Silicon Relat. Elem."},{"key":"10.1016\/j.bioorg.2026.110547_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.cdc.2020.100550","article-title":"Synthesis of novel aryl and coumarin substituted pyrazolo[1,5-a]pyrimidine derivatives as potent anti-inflammatory and anticancer agents","volume":"30","author":"Naik","year":"2020","journal-title":"Chem. Data Collect."},{"key":"10.1016\/j.bioorg.2026.110547_bb0090","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s11030-024-10906-9","article-title":"Review of the recent advances of pyrazole derivatives as selective COX-2 inhibitors for treating inflammation","volume":"29","author":"Ghoneim","year":"2025","journal-title":"Mol. Divers."},{"key":"10.1016\/j.bioorg.2026.110547_bb0095","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s11030-025-11220-8","article-title":"Novel pyrazole carboxylate derivatives as lonazolac bioisosteres with selective COX-2 inhibition: design, synthesis and anti-inflammatory activity","volume":"30","author":"Fadaly","year":"2025","journal-title":"Mol. Divers."},{"key":"10.1016\/j.bioorg.2026.110547_bb0100","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1039\/D4MD00135D","article-title":"New pyrazole\u2013pyridazine hybrids as selective COX-2 inhibitors: design, synthesis, molecular docking, in silico studies and investigation of their anti-inflammatory potential by evaluation of TNF-\u03b1, IL-6, PGE-2 and NO in LPS-induced RAW264.7 macrophages","volume":"15","author":"Osman","year":"2024","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110547_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104555","article-title":"Design and synthesis of pyrimidine-5-carbonitrile hybrids as COX-2 inhibitors: anti-inflammatory activity, ulcerogenic liability, histopathological and docking studies","volume":"108","author":"Alfayomy","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110547_bb0110","doi-asserted-by":"crossref","first-page":"7485","DOI":"10.3390\/molecules27217485","article-title":"New pyrimidine-5-carbonitriles as COX-2 inhibitors: design, synthesis, anticancer screening, molecular docking, and in silico ADME profile studies","volume":"27","author":"AL-Ghulikah","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110547_bb0115","doi-asserted-by":"crossref","first-page":"32296","DOI":"10.1039\/D3RA06088H","article-title":"Design, synthesis, and biological evaluation of new pyrimidine-5-carbonitrile derivatives as novel anti-cancer, dual EGFRWT\/COX-2 inhibitors with docking studies","volume":"13","author":"Reda","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.110547_bb0120","doi-asserted-by":"crossref","DOI":"10.1155\/bmri\/4477854","article-title":"Novel 1,2,4-Triazole-Thiopyrimidine hybrids as COX-2 inhibitors: synthesis, ADME profiling, antioxidant activity, and molecular docking","volume":"2026","author":"Karpenko","year":"2026","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bioorg.2026.110547_bb0125","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1021\/jm0009383","article-title":"Synthesis and SAR of a new series of COX-2-selective inhibitors: pyrazolo[1,5-\u03b1]pyrimidines","volume":"44","author":"Almansa","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110547_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2022.104015","article-title":"Optimization of pyrazolo[1,5-a]pyrimidine based compounds with pyridine scaffold: synthesis, biological evaluation and molecular modeling study","volume":"15","author":"Abdelgawad","year":"2022","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.bioorg.2026.110547_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115138","article-title":"Development of novel pyrazole, imidazo[1,2-b]pyrazole, and pyrazolo[1,5-a]pyrimidine derivatives as a new class of COX-2 inhibitors with immunomodulatory potential","volume":"249","author":"Ayman","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110547_bb0140","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00044-023-03022-0","article-title":"Novel benzo[4,5]imidazo[1,2- a]pyrimidine derivatives as selective Cyclooxygenase-2 inhibitors: design, synthesis, docking studies, and biological evaluation","volume":"32","author":"Bayanati","year":"2023","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2026.110547_bb0145","doi-asserted-by":"crossref","first-page":"21620","DOI":"10.1039\/D3NJ04438F","article-title":"Design, synthesis, molecular docking and molecular dynamic studies of novel benzimidazole\u2013thiazole derivatives as potent and selective COX-2 inhibitors","volume":"47","author":"Irmak","year":"2023","journal-title":"New J. Chem."},{"key":"10.1016\/j.bioorg.2026.110547_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108181","article-title":"Exploration of anti-inflammatory activity of pyrazolo[3,4-d]pyrimidine\/1,2,4-oxadiazole hybrids as COX-2, 5-LOX and NO release inhibitors: design, synthesis, in silico and in vivo studies","volume":"156","author":"Aziz","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110547_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117499","article-title":"Unveiling a novel pyrazolopyrimidine scaffold as a dual COX-2\/5-LOX inhibitor with immunomodulatory potential: design, synthesis, target prediction, anti-inflammatory activity, and ADME-T with docking simulation","volume":"290","author":"Ragab","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110547_bb0160","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1039\/D1MD00280E","article-title":"Non-steroidal anti-inflammatory drugs: recent advances in the use of synthetic COX-2 inhibitors","volume":"13","author":"Ahmadi","year":"2022","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110547_bb0165","doi-asserted-by":"crossref","first-page":"10285","DOI":"10.1039\/C5RA27017K","article-title":"Design and synthesis of potent N-phenylpyrimidine derivatives for the treatment of skin cancer","volume":"6","author":"Chaube","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.110547_bb0170","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1080\/00397910701473317","article-title":"Novel cyanoketene N,S-acetals and pyrazole derivatives using potassium 2-cyanoethylene-1-thiolates","volume":"37","author":"Elgemeie","year":"2007","journal-title":"Synth. Commun."},{"key":"10.1016\/j.bioorg.2026.110547_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/ph17121667","article-title":"Design, synthesis and molecular modeling of pyrazolo[1,5-a]pyrimidine derivatives as dual inhibitors of CDK2 and TRKA kinases with antiproliferative activity","volume":"17","author":"Attia","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2026.110547_bb0180","doi-asserted-by":"crossref","first-page":"13024","DOI":"10.1016\/j.tet.2007.10.014","article-title":"A highly efficient regioselective one-pot synthesis of 2,3,6-trisubstituted pyridines and 2,7,7-trisubstituted tetrahydroquinolin-5-ones using K5CoW12O40\u00b73H2O as a heterogeneous recyclable catalyst","volume":"63","author":"Kantevari","year":"2007","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2026.110547_bb0185","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/cbdd.13019","article-title":"Design, synthesis, and preliminary bioactivity evaluation of N-benzylpyrimidin-2-amine derivatives as novel histone deacetylase inhibitor","volume":"90","author":"Zhou","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2026.110547_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111843","article-title":"Synthesis, biological and molecular dynamics investigations with a series of triazolopyrimidine\/triazole-based benzenesulfonamides as novel carbonic anhydrase inhibitors","volume":"185","author":"Said","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110547_bb0195","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00706-008-0896-2","article-title":"Synthesis and reactions of thiosemicarbazides, triazoles, and Schiff bases as antihypertensive \u03b1-blocking agents","volume":"139","author":"Abdel-Wahab","year":"2008","journal-title":"Monatsh. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110547_bb0200","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.3390\/molecules18022084","article-title":"The reaction of ethyl 2-oxo-2H-chromene-3-carboxylate with hydrazine hydrate","volume":"18","author":"Abdel-Aziz","year":"2013","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/j.bioorg.2026.110547_bb0205","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/17415993.2011.601869","article-title":"Thiosemicarbazides: synthesis and reactions","volume":"32","author":"Metwally","year":"2011","journal-title":"J. Sulfur Chem."},{"key":"10.1016\/j.bioorg.2026.110547_bb0210","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1039\/C8OB00138C","article-title":"The Curtius rearrangement: mechanistic insight and recent applications in natural product syntheses","volume":"16","author":"Ghosh","year":"2018","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2026.110547_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21062237","article-title":"Analysis of the activity and expression of cyclooxygenases COX1 and COX2 in THP-1 monocytes and macrophages cultured with BiodentineTM silicate cement","volume":"21","author":"Barczak","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110547_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106724","article-title":"Fragment merging approach for the design of thiazole\/thiazolidine clubbed pyrazoline derivatives as anti-inflammatory agents: synthesis, biopharmacological evaluation and molecular modeling studies","volume":"139","author":"Elgohary","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110547_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107727","article-title":"Novel anti-inflammatory agents featuring phenoxy acetic acid moiety as a pharmacophore for selective COX-2 inhibitors: synthesis, biological evaluation, histopathological examination and molecular modeling investigation","volume":"152","author":"Elgohary","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110547_bb0230","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2022.2162511","article-title":"Design, synthesis, and biological investigation of oxadiazolyl, thiadiazolyl, and pyrimidinyl linked antipyrine derivatives as potential non-acidic anti-inflammatory agents","volume":"38","author":"Al-Sanea","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110547_bb0235","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1080\/17568919.2025.2545171","article-title":"Novel di-aryl chalcone derived pyrazole linked to methane sulfonyl pharmacophore as potent selective COX-2 inhibitors; design, synthesis, molecular modeling, in vitro and in vivo anti-inflammatory activities","volume":"17","author":"Abd El-Hameed","year":"2025","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110547_bb0240","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bph.14530","article-title":"Prostaglandin-cytokine crosstalk in chronic inflammation","volume":"176","author":"Yao","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110547_bb0245","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1002\/jcb.23290","article-title":"Anti-inflammatory effect of pelubiprofen, 2-[4-(oxocyclohexylidenemethyl)-phenyl]propionic acid, mediated by dual suppression of COX activity and LPS-induced inflammatory gene expression via NF-\u03baB inactivation","volume":"112","author":"Shin","year":"2011","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bioorg.2026.110547_bb0250","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1021\/np500563b","article-title":"Pimaradienoic acid inhibits inflammatory pain: inhibition of NF-\u03baB activation and cytokine production and activation of the NO-cyclic GMP-protein kinase G-ATP-sensitive potassium channel signaling pathway","volume":"77","author":"Possebon","year":"2014","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2026.110547_bb0255","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/PL00005345","article-title":"The inflammatory reaction induced by formalin in the rat paw","volume":"359","author":"Damas","year":"1999","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110547_bb0260","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3344\/kjp.2011.24.4.179","article-title":"Roles of serotonergic and adrenergic receptors in the antinociception of selective cyclooxygenase-2 inhibitor in the rat spinal cord","volume":"24","author":"Jeong","year":"2011","journal-title":"Korean J. Pain."},{"key":"10.1016\/j.bioorg.2026.110547_bb0265","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184367","article-title":"Animal models of inflammation for screening of anti-inflammatory drugs: implications for the discovery and development of phytopharmaceuticals","volume":"20","author":"Patil","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110547_bb0270","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.2337\/diabetes.51.7.2249","article-title":"Elevated spinal cyclooxygenase and prostaglandin release during hyperalgesia in diabetic rats","volume":"51","author":"Freshwater","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.bioorg.2026.110547_bb0275","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/00000539-200204000-00035","article-title":"The role of cyclooxygenase-1 and -2 in the rat formalin test","volume":"94","author":"Yamamoto","year":"2002","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.bioorg.2026.110547_bb0280","series-title":"Cyclooxygenase pathway of the Arachidonate Cascade","author":"Seta","year":"2012"},{"key":"10.1016\/j.bioorg.2026.110547_bb0285","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.2174\/0929867325666180514112124","article-title":"Cyclooxygenase-2 inhibitors as a therapeutic target in inflammatory diseases","volume":"26","author":"Ferrer","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110547_bb0290","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1255533","article-title":"Interleukin 6: at the interface of human health and disease","volume":"14","author":"Grebenciucova","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioorg.2026.110547_bb0295","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23450","article-title":"Probenecid ameliorates testosterone-induced benign prostatic hyperplasia: implications of PGE-2 on ADAM-17\/EGFR\/ERK1\/2 signaling cascade","volume":"37","author":"Abdel-Fattah","year":"2023","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.bioorg.2026.110547_bb0300","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10787-022-01123-7","article-title":"Cyclooxygenase-2 activates EGFR-ERK1\/2 pathway via PGE2-mediated ADAM-17 signaling in testosterone-induced benign prostatic hyperplasia","volume":"31","author":"Abo-El Fetoh","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.bioorg.2026.110547_bb0305","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1080\/01480545.2025.2559844","article-title":"The protective effects of neferine against paracetamol-induced liver injury are associated with the activation of SIRT1\/Nrf2\/HO-1 signaling pathway and inhibition of NF-kappa B\/TNF-alpha\/iNOS\/COX-II cascade","volume":"48","author":"Altowijri","year":"2025","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.bioorg.2026.110547_bb0310","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jtcme.2019.02.004","article-title":"Protective effects of luteolin on injury induced inflammation through reduction of tissue uric acid and pro-inflammatory cytokines in rats","volume":"10","author":"Lodhi","year":"2019","journal-title":"J. Tradit. Complement. Med."},{"key":"10.1016\/j.bioorg.2026.110547_bb0315","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1346054","article-title":"Mechanistic evaluation of antiarthritic and anti-inflammatory effect of campesterol ester derivatives in complete Freund\u2019s adjuvant-induced arthritic rats","volume":"14","author":"Nazir","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110547_bb0320","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.70214","article-title":"Multitargeted anti-inflammatory agents: novel pyrazole and pyrazolo[1,5-a]pyrimidine carbonic anhydrase and COX-2 inhibitors with optimal in vivo efficacy and low toxicity","volume":"87","author":"Fakhry","year":"2026","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2026.110547_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13071732","article-title":"Novel benzenesulfonamide derivatives of 5\u2019-aminospirotriazolotriazine exhibit anti-inflammatory activity by suppressing pro-inflammatory mediators: in vitro and in vivo evaluation using a rat model of carrageenan-induced paw edema","volume":"13","author":"Hamed","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.bioorg.2026.110547_bb0330","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/head.12769","article-title":"The pharmacology of indomethacin","volume":"56","author":"Lucas","year":"2016","journal-title":"Headache"},{"key":"10.1016\/j.bioorg.2026.110547_bb0335","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2147\/JPR.S75160","article-title":"New insights into the use of currently available non-steroidal anti-inflammatory drugs","volume":"8","author":"Brune","year":"2015","journal-title":"J. Pain Res."},{"key":"10.1016\/j.bioorg.2026.110547_bb0340","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/sj.bjp.0703955","article-title":"Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge","volume":"132","author":"Gretzer","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110547_bb0345","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1443-9573.2003.t01-1-00115.x","article-title":"Experimental study of the safety of the selective COX-2 inhibitor, celecoxib, for gastric mucosa","volume":"4","author":"Li","year":"2003","journal-title":"Chin. J. Dig. Dis."},{"key":"10.1016\/j.bioorg.2026.110547_bb0350","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.toxrep.2019.04.010","article-title":"Comparative effect of indomethacin (IndoM) on the enzymes of carbohydrate metabolism, brush border membrane and oxidative stress in the kidney, small intestine and liver of rats","volume":"6","author":"Khan","year":"2019","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.bioorg.2026.110547_bb0355","doi-asserted-by":"crossref","first-page":"482","DOI":"10.22159\/ajpcr.2018.v11i6.25487","article-title":"Comparing the toxic effects of nonsteroidal anti-inflammatory drugs (celecoxib and ibuprofen) on heart, liver, and kidney in rats","volume":"11","author":"Aziz","year":"2018","journal-title":"Asian J. Pharm. Clin. Res."},{"key":"10.1016\/j.bioorg.2026.110547_bb0360","series-title":"Seldin and Giebisch\u2019s The Kidney: Physiology and Pathophysiology","first-page":"487","article-title":"Eicosanoids and renal function","author":"Breyer","year":"2013"},{"key":"10.1016\/j.bioorg.2026.110547_bb0365","series-title":"Chronic Renal Disease","first-page":"1071","article-title":"Nonsteroidal Antiinflammatory drugs and opioids in chronic kidney disease","author":"Clive","year":"2020"},{"key":"10.1016\/j.bioorg.2026.110547_bb0370","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.bcp.2003.09.023","article-title":"Indomethacin-induced renal damage: role of oxygen free radicals","volume":"67","author":"Basivireddy","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110547_bb0375","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00204-005-0658-4","article-title":"Indomethacin induces free radical-mediated changes in renal brush border membranes","volume":"79","author":"Basivireddy","year":"2005","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.bioorg.2026.110547_bb0380","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejphar.2013.10.035","article-title":"Effects of rebamipide on nephrotoxicity associated with selected NSAIDs in rats","volume":"720","author":"Wood","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110547_bb0385","doi-asserted-by":"crossref","first-page":"30647","DOI":"10.1039\/D4RA04686B","article-title":"NSAIDs between past and present; a long journey towards an ideal COX-2 inhibitor lead","volume":"14","author":"Khalil","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.110547_bb0390","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.tox.2007.12.006","article-title":"Cardiac troponin is the most effective translational safety biomarker for myocardial injury in cardiotoxicity","volume":"245","author":"O\u2019Brien","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.bioorg.2026.110547_bb0395","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1517\/14740338.4.3.457","article-title":"Troponin as a marker of myocardiac damage in drug-induced cardiotoxicity","volume":"4","author":"Adamcov\u00e1","year":"2005","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.bioorg.2026.110547_bb0400","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1586\/14737159.6.5.685","article-title":"Blood cardiac troponin in toxic myocardial injury: archetype of a translational safety biomarker","volume":"6","author":"O\u2019Brien","year":"2006","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"10.1016\/j.bioorg.2026.110547_bb0405","article-title":"Targeting NF-\u03baB signaling with natural products: a promising therapeutic strategy for cardiovascular diseases","volume":"16","author":"Liu","year":"2026","journal-title":"Biomolecules"},{"key":"10.1016\/j.bioorg.2026.110547_bb0410","doi-asserted-by":"crossref","first-page":"33494","DOI":"10.1021\/acsomega.4c00870","article-title":"New Diaryl-1,2,4-triazolo[3,4- a]pyrimidine hybrids as selective COX-2\/sEH dual inhibitors with potent analgesic\/anti-inflammatory and cardioprotective properties","volume":"9","author":"Al-Wahaibi","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2026.110547_bb0415","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1021\/cr00002a004","article-title":"A survey of Hammett substituent constants and resonance and field parameters","volume":"91","author":"Hansch","year":"1991","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2026.110547_bb0420","doi-asserted-by":"crossref","first-page":"10188","DOI":"10.1021\/acs.joc.7b01698","article-title":"Steric scale of common substituents from rotational barriers of N-(o-substituted aryl)thiazoline-2-thione atropisomers","volume":"82","author":"Belot","year":"2017","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2026.110547_bb0425","doi-asserted-by":"crossref","first-page":"A174","DOI":"10.1021\/ed073pA174.2","article-title":"Stereochemistry of organic compounds (Eliel, Ernest L.; Wilen, Samuel H.)","volume":"73","author":"McKelvey","year":"1996","journal-title":"J. Chem. Educ."},{"key":"10.1016\/j.bioorg.2026.110547_bb0435","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0005-2760(81)90077-1","article-title":"Enzyme immunoassay of prostaglandin F2\u03b1","volume":"663","author":"Yoko","year":"1981","journal-title":"Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism"},{"key":"10.1016\/j.bioorg.2026.110547_bb0440","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1002999","article-title":"Exploration of acute and chronic anti-inflammatory potential of Quercus leucotrichophora A. Camus extracts in Wistar rats: a mechanistic insight","volume":"14","author":"Saleem","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110547_bb0445","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/jvp.70001","article-title":"Recommendations for a complete reporting of statistical methods in veterinary pharmacology","volume":"48","author":"Villarino","year":"2025","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.bioorg.2026.110547_bb0450","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/00236772221140669","article-title":"Recommendations to improve use and reporting of statistics in animal experiments","volume":"57","author":"Rowe","year":"2023","journal-title":"Lab. Anim."},{"key":"10.1016\/j.bioorg.2026.110547_bb0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2019.01.008","article-title":"Design, synthesis and biological evaluation of certain CDK2 inhibitors based on pyrazole and pyrazolo[1,5-a]pyrimidine scaffold with apoptotic activity","volume":"86","author":"Ali","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110547_bb0460","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.661230","article-title":"Molecular docking and dynamics simulation revealed the potential inhibitory activity of ACEIs against SARS-CoV-2 targeting the h ACE2 receptor","volume":"9","author":"Al-karmalawy","year":"2021","journal-title":"Front. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826010837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826010837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:35:37Z","timestamp":1791261337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826010837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":91,"alternative-id":["S0045206826010837"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110547","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, structure\u2013activity relationship and in-silico studies of novel pyrazolo[1,5-a]pyrimidine derivatives as selective COX-2 inhibitors with promising anti-inflammatory activity and safety profile","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110547","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110547"}}